Phagenesis

About Phagenesis

Phagenesis is a pioneering company focused on developing innovative neurostimulation therapies to treat swallowing dysfunction, known as dysphagia. Their mission is to restore swallowing control, facilitate airway protection, and accelerate recovery for patients affected by brain injury or prolonged mechanical ventilation through non-surgical treatments.

Products & Services

Phagenyx® Neurostimulation System:A first-of-its-kind treatment using Pharyngeal Electrical Stimulation (PES) to restore swallowing control. It offers personalized stimulation levels, delivered early after injury, to enhance neurorehabilitation with minimal patient participation. The system is non-surgical, simple to integrate into care, and has over 10 years of clinical use in Europe.

Specialties

Neurostimulation Therapy Dysphagia Treatment Pharyngeal Electrical Stimulation (PES) Neurorehabilitation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series D T: - FT: Series D	A: 42000000 MR: - FA: $42M FAN: 42000000	D: 2024-03-04 FD: 2024-03-04	5 investors

Series D Latest

2024-03-04

$42.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Chad Hoskins

Chief Executive Officer

LinkedIn (Pro only)

C

Conor Mulrooney

Co-Founder & Chief Operating Officer

LinkedIn (Pro only)

S

Shaheen Hamdy

Co-Founder & Chief Scientific Officer

M

Marc Korenberg

Chief Financial Officer

B

Boris Deutschmann

Director European Sales

B

Buck Weller

VP US Therapy Development

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Phagenesis Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised